• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical value of new drugs in acute myeloid leukemia.

作者信息

Ossenkoppele Gert

机构信息

Amsterdam UMC, Location VUMC, The Netherlands.

出版信息

Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000223. eCollection 2019 Jun.

DOI:10.1097/HS9.0000000000000223
PMID:35309778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8925710/
Abstract
摘要

相似文献

1
Clinical value of new drugs in acute myeloid leukemia.新药在急性髓系白血病中的临床价值。
Hemasphere. 2019 Jun 30;3(Suppl). doi: 10.1097/HS9.0000000000000223. eCollection 2019 Jun.
2
Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemia.新型核苷类似物在急性髓系白血病治疗中的潜在作用。
Curr Opin Hematol. 2008 Mar;15(2):101-7. doi: 10.1097/MOH.0b013e3282f46e94.
3
Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia.评估预测儿童急性髓系白血病细胞遗传学和分子亚型的基因表达谱。
Haematologica. 2011 Feb;96(2):221-30. doi: 10.3324/haematol.2010.029660. Epub 2010 Oct 22.
4
[New Drugs in the Treatment of Acute Myeloid Leukemia in the Elderly].[老年急性髓系白血病治疗中的新药]
Klin Onkol. 2017 Summer;30(3):190-196. doi: 10.14735/amko2017190.
5
Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia.急性髓系白血病患者CXCR4表达的靶向正电子发射断层显像
Haematologica. 2016 Aug;101(8):932-40. doi: 10.3324/haematol.2016.142976. Epub 2016 May 12.
6
The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia.CRISPR/Cas9 这项高性能技术提高了人们对急性髓细胞白血病的认识和管理水平。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Sep;165(3):249-257. doi: 10.5507/bp.2021.048. Epub 2021 Aug 24.
7
Discovering Small Molecules that Overcome Differentiation Arrest in Acute Myeloid Leukemia发现可克服急性髓系白血病分化阻滞的小分子
8
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity.阻断增殖诱导配体（APRIL）信号通路可增强急性髓系白血病细胞的化疗敏感性。
Haematologica. 2008 Dec;93(12):1899-902. doi: 10.3324/haematol.13035. Epub 2008 Oct 6.
9
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.基于基因表达谱预测急性髓系白血病的分子亚型
Haematologica. 2009 Jan;94(1):131-4. doi: 10.3324/haematol.13299. Epub 2008 Oct 6.
10
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.自分泌 IGF-1/IGF-1R 信号通路导致急性髓细胞白血病中 PI3K/Akt 的持续激活：中和抗 IGF-1R 抗体的治疗价值。
Haematologica. 2010 Mar;95(3):415-23. doi: 10.3324/haematol.2009.010785. Epub 2009 Dec 8.

引用本文的文献

1
Association between increased mutation rates in DNMT3A and FLT3-ITD and poor prognosis of patients with acute myeloid leukemia.DNMT3A和FLT3-ITD突变率增加与急性髓系白血病患者预后不良之间的关联。
Exp Ther Med. 2019 Oct;18(4):3117-3124. doi: 10.3892/etm.2019.7891. Epub 2019 Aug 14.

本文引用的文献

1
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.BH3 模拟药物：为新型癌症药物开辟道路。
Cancer Cell. 2018 Dec 10;34(6):879-891. doi: 10.1016/j.ccell.2018.11.004.
2
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.维奈托克联合地西他滨或阿扎胞苷治疗初治老年急性髓系白血病患者。
Blood. 2019 Jan 3;133(1):7-17. doi: 10.1182/blood-2018-08-868752. Epub 2018 Oct 25.
3
A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia.一种新型异体即用型树突状细胞疫苗，用于治疗老年急性髓系白血病缓解后的患者。
Cancer Immunol Immunother. 2018 Oct;67(10):1505-1518. doi: 10.1007/s00262-018-2198-9. Epub 2018 Jul 23.
4
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.CPX-351（阿糖胞苷和柔红霉素）脂质体注射液与常规阿糖胞苷联合柔红霉素治疗新诊断的老年继发性急性髓系白血病患者的比较。
J Clin Oncol. 2018 Sep 10;36(26):2684-2692. doi: 10.1200/JCO.2017.77.6112. Epub 2018 Jul 19.
5
Novel Approaches to Acute Myeloid Leukemia Immunotherapy.急性髓系白血病免疫治疗的新方法。
Clin Cancer Res. 2018 Nov 15;24(22):5502-5515. doi: 10.1158/1078-0432.CCR-17-3016. Epub 2018 Jun 14.
6
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.ivosidenib 治疗 IDH1 突变复发性或难治性 AML 的持久缓解。
N Engl J Med. 2018 Jun 21;378(25):2386-2398. doi: 10.1056/NEJMoa1716984. Epub 2018 Jun 2.
7
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes.低甲基化药物联合免疫检查点抑制剂在急性髓系白血病和骨髓增生异常综合征中的应用。
Leukemia. 2018 May;32(5):1094-1105. doi: 10.1038/s41375-018-0070-8. Epub 2018 Feb 22.
8
Differentiation Syndrome Associated With Enasidenib, a Selective Inhibitor of Mutant Isocitrate Dehydrogenase 2: Analysis of a Phase 1/2 Study.与依尼西单抗相关的分化综合征，一种选择性突变型异柠檬酸脱氢酶 2 抑制剂：一项 1/2 期研究的分析。
JAMA Oncol. 2018 Aug 1;4(8):1106-1110. doi: 10.1001/jamaoncol.2017.4695.
9
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. Venetoclax 联合治疗复发/难治性急性髓系白血病及相关髓系恶性肿瘤的临床经验。
Am J Hematol. 2018 Mar;93(3):401-407. doi: 10.1002/ajh.25000. Epub 2017 Dec 23.
10
Which new agents will be incorporated into frontline therapy in acute myeloid leukemia?哪些新型药物将被纳入急性髓系白血病的一线治疗？
Best Pract Res Clin Haematol. 2017 Dec;30(4):312-316. doi: 10.1016/j.beha.2017.09.006. Epub 2017 Sep 22.